ArticleJournal of bone and mineral metabolism2021

Short-term efficacy and safety of zoledronate acid or denosumab in Japanese patients with postmenopausal osteoporosis.

Yumejiro Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.